Treatment of venous thromboembolism in cancer patients with tinzaparin beyond 6 months. TiCAT study

Luis Jara-Palomares (Seville, Spain), Luis Jara-Palomares, Aurora Solier-Lopez, Teresa Elias-Hernandez, Lucia Marin-Barrera, Maribel Asensio-Cruz, Lionel Suarez-Valdivia, Isabel Blasco-Esquivias, Maria Rodriguez de la Borbolla, Remedios Otero-Candelera

Source: International Congress 2016 – Pulmonary hypertension and chronic thromboembolic pulmonary hypertension
Session: Pulmonary hypertension and chronic thromboembolic pulmonary hypertension
Session type: Poster Discussion
Number: 3604
Disease area: Pulmonary vascular diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Luis Jara-Palomares (Seville, Spain), Luis Jara-Palomares, Aurora Solier-Lopez, Teresa Elias-Hernandez, Lucia Marin-Barrera, Maribel Asensio-Cruz, Lionel Suarez-Valdivia, Isabel Blasco-Esquivias, Maria Rodriguez de la Borbolla, Remedios Otero-Candelera. Treatment of venous thromboembolism in cancer patients with tinzaparin beyond 6 months. TiCAT study. Eur Respir J 2016; 48: Suppl. 60, 3604

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Occult cancer in patients with acute venous thromboembolism: Why, when and where to investigate
Source: International Congress 2016 – Pulmonary hypertension and chronic thromboembolic pulmonary hypertension
Year: 2016

Tinzaparin and vitamin K antagonist (VKA) use in patients with cancer associated venous thromboembolism (VTE): A cohort study
Source: International Congress 2014 – Acute pulmonary embolism
Year: 2014


Long-term low molecular weight heparin treatment in cancer associated venous thromboembolism patients
Source: International Congress 2015 – Pulmonary circulation: pulmonary embolism and chronic thromboembolic pulmonary hypertension
Year: 2015

Risk of recurrent venous thromboembolism in COPD patients: results from a prospective cohort study
Source: Eur Respir J, 50 (1) 1700094; 10.1183/13993003.00094-2017
Year: 2017



Search predictive factors of recurrence in venous thromboembolic disease associated with cancer after withdrawal of the anticoagulation. HISPALIS study
Source: International Congress 2016 – Acute pulmonary embolism
Year: 2016

Pulmonary embolism in the multicentre advanced study for a thromboembolism registry (MASTER): study design and patients recruited
Source: Eur Respir J 2005; 26: Suppl. 49, 595s
Year: 2005

Ambulatory treatment of low-risk pulmonary embolism in fragile patients: a subgroup analysis of the multinational Home Treatment of Pulmonary Embolism (HoT-PE) Trial
Source: Eur Respir J, 56 (4) 2000663; 10.1183/13993003.00663-2020
Year: 2020



Venous thromboembolism in patients immobilized at home
Source: International Congress 2015 – Pulmonary circulation: pulmonary embolism and chronic thromboembolic pulmonary hypertension
Year: 2015


Characteristics of the patiens diagnosed with pulmonary thromboembolism in the last 10 years
Source: Annual Congress 2013 –Pulmonary circulation: acute pulmonary tromboembolism
Year: 2013


Rivaroxaban for treatment of venous thromboembolism. A real-life perspective in 103 patients
Source: International Congress 2014 – Acute pulmonary embolism
Year: 2014


Venous thromboembolic (VTE) in patients with ALS: an incidence study
Source: Virtual Congress 2021 – Home mechanical ventilation: organisation and outcomes
Year: 2021


Mortality and recurrence during a follow-up of 2 years of pulmonary embolism: Role of anticoagulant therapy
Source: Annual Congress 2010 - Pulmonary embolism
Year: 2010

How to prevent VTE in COVID-19 patients?: Chinese & European perspectives
Source: ERS webinar 2020: How to prevent VTE in COVID-19 patients?: Chinese & European perspectives
Year: 2020

Risk of pulmonary embolism and deep venous thrombosis in patients with asthma: a nationwide case?control study from Sweden
Source: Eur Respir J , 49 (2) 1601014; DOI: 10.1183/13993003.01014-2016
Year: 2017



Venous thromboembolism prophylaxis in hospitalised patients with pneumonia: a prospective survey
Source: Annual Congress 2009 - Pulmonary embolism and cardiovascular diseases
Year: 2009


Evaluation of the PADIS score stratifying risk for venous thromboembolism recurrence after a first unprovoked pulmonary embolism: results from the REVERSE study
Source: Eur Respir J, 59 (2) 2101801; 10.1183/13993003.01801-2021
Year: 2022



Clinical characteristics of elderly patients with pulmonary embolism and risk factors for recurrence
Source: International Congress 2016 – Pulmonary hypertension and pulmonary embolism: from the bench to the bedside
Year: 2016

Venous thromboembolism and pulmonary cancer: A ten years series
Source: Annual Congress 2010 - Best supportive care and palliation for lung cancer patients
Year: 2010


Clinical profile and mortality of patients with pulmonary embolism and cancer
Source: International Congress 2015 – Pulmonary circulation: the story of fresh and old clots
Year: 2015

Venous thromboembolism in people with idiopathic pulmonary fibrosis: a population-based study
Source: Eur Respir J 2014; 44: 1714-1715
Year: 2014